Answers are grounded in this paper and cite their sources.
The lack of well-validated biomarkers for monitoring disease activity, predicting future clinical outcomes and the effect of therapeutic interventions highlights the need to find new biomarkers in chronic obstructive pulmonary disease (COPD). In recent years, extensive research has gone into identifying and attempting to validate relevant diagnostic biomarkers of disease activity and therapeutic response.1 A […]
No takes yet. Share an insight, caveat, or question.
Cazzola et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: